King Fahad Medical City; Gastroentrology
Riyadh, Saudi Arabia
Hospital in Riyadh
Prince Abdulaziz Ibn Musaid Ibn Jalawi St, St، Riyadh 12231
About King Fahad Medical City; Gastroentrology
King Fahd Medical City is a medical facility in Riyadh, Saudi Arabia. The complex consists of four hospitals: The Obstetrics & Gynecology Hospital, The Specialist Hospital, The Rehabilitation Hospital, and The Pediatric Hospital. It was built at a cost of $633 million.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Clinical Trials at King Fahad Medical City; Gastroentrology
During the past decade, King Fahad Medical City; Gastroentrology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
2009-04-11
2014-11-18
Completed
1,842
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF
2011-11-30
2013-05-12
Completed
28
A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC)
2017-01-19
2018-11-12
Terminated
15
A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice
2017-01-26
2017-12-12
Terminated
8
A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)
2017-08-25
2023-01-17
Completed
653
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer
2018-12-19
2022-10-12
Completed
160
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at King Fahad Medical City; Gastroentrology
According to Clinical.Site data, the most researched conditions in "King Fahad Medical City; Gastroentrology" are
"Rheumatoid Arthritis" (2 trials), "HER2-Positive Early Breast Cancer" (1 trials), "Hepatitis B, Chronic" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "King Fahad Medical City; Gastroentrology" in a lesser frequency.
Clinical Trials Intervention Types at King Fahad Medical City; Gastroentrology
Most popular intervention types in "King Fahad Medical City; Gastroentrology" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "No intervention" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab Placebo" (1 trials), "Paclitaxel" (1 trials) and "Pertuzumab IV" (1 trials). Other intervention names were less common.
Clinical Trials Genders at King Fahad Medical City; Gastroentrology
The vast majority of trials in "King Fahad Medical City; Gastroentrology" are
6 trials for "All" genders.
Clinical Trials Status at King Fahad Medical City; Gastroentrology
Currently, there are NaN active trials in "King Fahad Medical City; Gastroentrology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in King Fahad Medical City; Gastroentrology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in King Fahad Medical City; Gastroentrology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".